Author: Syed Faraz Ahmed; Ahmed A. Quadeer; Matthew R. McKay
Title: Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies Document date: 2020_2_4
ID: 7i52vltp_25
Snippet: Mapping the residues of the B cell epitopes onto the available structure of the SARS-CoV S protein revealed that the linear epitopes (Table 4 ) map to seemingly less-exposed regions, away from the most exposed region, the "spike head" (Figure 3a) . In contrast, all discontinuous B cell epitopes (Table 5) map onto the spike head region (Figure 3b, top panel) , which contains the receptor-binding motif of the SARS-CoV S protein (F. Li, 2005) . We o.....
Document: Mapping the residues of the B cell epitopes onto the available structure of the SARS-CoV S protein revealed that the linear epitopes (Table 4 ) map to seemingly less-exposed regions, away from the most exposed region, the "spike head" (Figure 3a) . In contrast, all discontinuous B cell epitopes (Table 5) map onto the spike head region (Figure 3b, top panel) , which contains the receptor-binding motif of the SARS-CoV S protein (F. Li, 2005) . We observe that few residues of the discontinuous epitopes that lie . CC-BY-NC 4.0 International license author/funder. It is made available under a The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.02.03.933226 doi: bioRxiv preprint within the receptor-binding motif are identical within SARS-CoV and SARS-CoV-2 (Figure 3b ). It has been reported recently that SARS-CoV-2 is able to bind to the same receptor as SARS-CoV (ACE2) for cell entry, despite having multiple amino acid differences with SARS-CoV's receptor-binding motif (Hoffmann et al., 2020; Letko & Munster, 2020; Lu et al., 2020; Zhou et al., 2020) . Whether the antibodies specific to this motif maintain their binding and elicit an immune response against SARS-CoV-2 warrants further experimental investigation.
Search related documents:
Co phrase search for related documents- amino acid and cell entry: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- amino acid and cell epitope: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- amino acid and discontinuous epitope: 1, 2, 3, 4
- amino acid and experimental investigation: 1
- amino acid and head region: 1, 2, 3
- amino acid and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- amino acid and linear epitope: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- amino acid and recently report: 1
- amino acid and receptor bind: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- available structure and cell entry: 1, 2, 3
- available structure and cell epitope: 1, 2, 3
- available structure and immune response: 1, 2
- cell entry and head region: 1, 2, 3
- cell entry and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- cell entry and linear epitope: 1, 2, 3
- cell entry and motif specific antibody: 1
- cell entry and recently report: 1, 2, 3, 4
- cell epitope and discontinuous epitope: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- cell epitope and head region: 1
Co phrase search for related documents, hyperlinks ordered by date